The accuracy and robustness of plasma biomarker models for amyloid PET positivity

被引：0
|
作者：
Andréa L. Benedet
Wagner S. Brum
Oskar Hansson
Thomas K. Karikari
Eduardo R. Zimmer
Henrik Zetterberg
Kaj Blennow
Nicholas J. Ashton
机构：
[1] Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry
[2] The Sahlgrenska Academy,Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging
[3] University of Gothenburg,Graduate Program in Biological Sciences: Biochemistry
[4] McGill University,Clinical Memory Research Unit, Department of Clinical Sciences
[5] Montreal,Memory Clinic
[6] Universidade Federal do Rio Grande do Sul (UFRGS),Department of Psychiatry
[7] Malmö,Department of Pharmacology
[8] Lund University,Graduate Program in Biological Sciences: Pharmacology and Therapeutics
[9] Skåne University Hospital,Clinical Neurochemistry Laboratory
[10] University of Pittsburgh,Department of Neurodegenerative Disease
[11] UFRGS,Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[12] UFRGS,undefined
[13] Sahlgrenska University Hospital,undefined
[14] UCL Institute of Neurology,undefined
[15] UK Dementia Research Institute at UCL,undefined
[16] Hong Kong Center for Neurodegenerative Diseases,undefined
[17] the Sahlgrenska Academy at the University of Gothenburg,undefined
[18] King’s College London,undefined
[19] Institute of Psychiatry,undefined
[20] Psychology & Neuroscience,undefined
[21] Maurice Wohl Clinical Neuroscience Institute,undefined
[22] NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Plasma biomarker; Mass spectrometry; Immunoassay; Alzheimer’s disease; ADNI; p-tau181; GFAP; NfL;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The accuracy and robustness of plasma biomarker models for amyloid PET positivity
    Benedet, Andrea L.
    Brum, Wagner S.
    Hansson, Oskar
    Initiative, Alzheimer's Disease Neuroimaging
    Karikari, Thomas K.
    Zimmer, Eduardo R.
    Zetterberg, Henrik
    Blennow, Kaj
    Ashton, Nicholas J.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [2] Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
    Pyun, Jung-Min
    Ryu, Ji Sun
    Lee, Ryan
    Shim, Kyu Hawn
    Youn, Young Chul
    Ryoo, Nayoung
    Han, Sang-Won
    Park, Young Ho
    Kang, Sungmin
    An, Seong Soo A.
    Kim, SangYun
    CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 749 - 755
  • [3] Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET
    Cogswell, Petrice M.
    Wiste, Heather J.
    Weigand, Stephen D.
    Therneau, Terry M.
    Griswold, Michael E.
    Braunstein, Joel B.
    West, Tim
    Verghese, Philip B.
    Graff-Radford, Jonathan
    Algeciras-Schimnich, Alicia
    Lowe, Val J.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Knopman, David S.
    Vemuri, Prashanthi
    Petersen, Ronald C.
    Jack Jr, Clifford R.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [4] Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
    Sarah K. Royse
    Davneet S. Minhas
    Brian J. Lopresti
    Alice Murphy
    Tyler Ward
    Robert A. Koeppe
    Santiago Bullich
    Susan DeSanti
    William J. Jagust
    Susan M. Landau
    Alzheimer's Research & Therapy, 13
  • [5] Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
    Royse, Sarah K.
    Minhas, Davneet S.
    Lopresti, Brian J.
    Murphy, Alice
    Ward, Tyler
    Koeppe, Robert A.
    Bullich, Santiago
    DeSanti, Susan
    Jagust, William J.
    Landau, Susan M.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [6] Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes
    Beaufils, Emilie
    Vercouillie, Johnny
    Vierron, Emilie
    Cottier, Jean-Philippe
    Camus, Vincent
    Mondon, Karl
    Guilloteau, Denis
    Hommet, Caroline
    Ribeiro, Maria Joao
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : E103 - E108
  • [7] Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
    K Höglund
    S Kern
    A Zettergren
    A Börjesson-Hansson
    H Zetterberg
    I Skoog
    K Blennow
    Translational Psychiatry, 2017, 7 : e995 - e995
  • [8] Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
    Hoglund, K.
    Kern, S.
    Zettergren, A.
    Borjesson-Hansson, A.
    Zetterberg, H.
    Skoog, I.
    Blennow, K.
    TRANSLATIONAL PSYCHIATRY, 2017, 7 : e995 - e995
  • [9] Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
    Jack, Clifford R., Jr.
    Wiste, Heather J.
    Weigand, Stephen D.
    Knopman, David S.
    Lowe, Val
    Vemuri, Prashanthi
    Mielke, Michelle M.
    Jones, David T.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Gregg, Brian E.
    Pankratz, Vernon S.
    Petersen, Ronald C.
    NEUROLOGY, 2013, 81 (20) : 1732 - 1740
  • [10] Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity
    Cerman, J.
    Laczo, J.
    Vyhnalek, M.
    Malinovska, J.
    Hanzalova, J.
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (02) : 173 - 179
12345